Bias in reporting clinical trials

被引:49
作者
Bardy, AH [1 ]
机构
[1] Natl Agcy Med, Dept Pharmacol, FIN-00301 Helsinki, Finland
关键词
bias; publication bias; clinical trials; quality control;
D O I
10.1046/j.1365-2125.1998.00759.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims The primary aim of the present study was to identify possible occurrence of selective reporting of the results of clinical trials to the Finnish National Agency for Medicines. Selective reporting may lead to poorly informed action or inaction by regulatory authorities. Methods In 1987, 274 clinical drug trials were notified to the Finnish National Agency for Medicines. By December 1993, final reports had been received from 68 of these trials and statements that the trial had been suspended from 24 trials. The sponsors of the non-reported trials were requested to report the outcome. The outcomes, ii any, of all reported and non-reported trials were classified as positive, inconclusive or negative. Results The total number of trials with positive, inconclusive or negative outcome were 111, 33 and 44, respectively; the outcomes of 86 trials could not be assessed. Final reports were received from 42/111 (38%) trials with positive, 6/33 (18%) with inconclusive and 9/14 (20%) with negative outcomes. Conclusions Substantial evidence of selective reporting was detected, since trials with positive outcome resulted more often in submission of final report to regulatory authority than those with inconclusive or negative outcomes.
引用
收藏
页码:147 / 150
页数:4
相关论文
共 13 条
[1]  
Bardy AH, 1996, THERAPIE, V51, P382
[2]   GETTING TO GRIPS WITH COCHRANE,ARCHIE AGENDA [J].
CHALMERS, I ;
DICKERSIN, K ;
CHALMERS, TC .
BMJ-BRITISH MEDICAL JOURNAL, 1992, 305 (6857) :786-788
[3]   UNDERREPORTING RESEARCH IS SCIENTIFIC MISCONDUCT [J].
CHALMERS, I .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (10) :1405-1408
[5]   INCORPORATING VARIATIONS IN THE QUALITY OF INDIVIDUAL RANDOMIZED TRIALS INTO METAANALYSIS [J].
DETSKY, AS ;
NAYLOR, CD ;
OROURKE, K ;
MCGEER, AJ ;
LABBE, KA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (03) :255-265
[6]   PUBLICATION BIAS IN CLINICAL RESEARCH [J].
EASTERBROOK, PJ ;
BERLIN, JA ;
GOPALAN, R ;
MATTHEWS, DR .
LANCET, 1991, 337 (8746) :867-872
[7]   DATA-PROOF PRACTICE [J].
HORTON, R .
LANCET, 1993, 342 (8886-7) :1499-1499
[8]   Discrepancies between meta-analyses and subsequent large randomized, controlled trials [J].
LeLorier, J ;
Gregoire, G ;
Benhaddad, A ;
Lapierre, J ;
Derderian, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (08) :536-542
[9]   PUBLICATION BIAS - ITS IMPLICATIONS FOR CLINICAL-PHARMACOLOGY [J].
LEVY, G .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (02) :115-119
[10]  
*NAT AG MED FINL, 1994, CLIN TRIALS MED PROD